Novartis Archives - Express Pharma

Cipla acquires brand, trademark rights for anti-diabetic drug Vysov in India

Sanofi ends research in diabetes, narrows units to spur profit

US FDA approves generic versions of Novartis blockbuster MS treatment

Drugmakers slash prices in China to get on reimbursement list

Biofourmis partners with Novartis

Novartis gets US nod for long-delayed Amgen copycat

Novartis arthritis drug fails to prove it is significantly better than rival

Novartis’ Zolgensma study halted by FDA amid safety questions

GSK to sell two vaccines in $1.1 billion deal to focus on newer treatments

Novartis MS drug cuts relapse rate by half compared to Sanofi medicine